MedTrace Logo

I-FABP as a Predictor of Gastrointestinal Involvement in Pediatric IgA Vasculitis

NCT07664228 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-06-24

No results posted yet for this study

Summary

This prospective observational study aims to evaluate plasma intestinal fatty acid-binding protein (I-FABP) levels in children with IgA vasculitis and investigate their association with gastrointestinal involvement. Blood samples will be collected at diagnosis and during follow-up 2-4 weeks later. The study will assess the potential value of plasma I-FABP as a biomarker for gastrointestinal involvement in pediatric IgA vasculitis.

Conditions

  • IgA Vasculitis
  • Gastrointestinal Involvement

Interventions

DIAGNOSTIC_TEST

Plasma I-FABP Measurement

Blood samples are collected and plasma I-FABP levels are measured to evaluate gastrointestinal involvement in pediatric IgA vasculitis.

Sponsors & Collaborators

  • Bursa City Hospital

    lead OTHER_GOV

Principal Investigators

  • Tuba Kurt, MD, Associate Professor · Health Sciences University Bursa City Hospital, Department of Pediatric Rheumatology

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-15
Primary Completion
2027-02-15
Completion
2027-05-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07664228 on ClinicalTrials.gov